Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder

NCT00108836 ·Status: COMPLETED ·Phase: PHASE2

Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

NCT00219349 ·Status: COMPLETED ·Phase: PHASE4

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

NCT00106860 ·Status: COMPLETED ·Phase: PHASE3

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

NCT06480383 ·Status: RECRUITING ·Phase: PHASE2

Experimental Medication For the Treatment of Generalized Anxiety Disorder

NCT00097708 ·Status: COMPLETED ·Phase: PHASE3

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

NCT00738738 ·Status: WITHDRAWN ·Phase: PHASE3

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

NCT00542685 ·Status: COMPLETED ·Phase: PHASE3

A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

NCT00735267 ·Status: TERMINATED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

NCT04598867 ·Status: UNKNOWN ·Phase: PHASE3

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

NCT06701903 ·Status: RECRUITING ·Phase: PHASE2

Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults

NCT00601965 ·Status: COMPLETED ·Phase: NA

Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

NCT00616655 ·Status: COMPLETED ·Phase: PHASE2

Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders

NCT03033056 ·Status: COMPLETED

A Study of Duloxetine in Elderly Generalized Anxiety Disorder

NCT01118780 ·Status: COMPLETED ·Phase: PHASE4

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

NCT00658372 ·Status: TERMINATED ·Phase: PHASE3

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008 ·Status: TERMINATED ·Phase: PHASE3

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

NCT00912145 ·Status: COMPLETED ·Phase: PHASE1

Randomized Trial of Adult Participants With Generalized Anxiety Disorder

NCT03829241 ·Status: COMPLETED ·Phase: PHASE3

Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder

NCT00397098 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

NCT05738850 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

NCT05941442 ·Status: TERMINATED ·Phase: PHASE2

Study Of Generalized Anxiety Disorder

NCT00135525 ·Status: COMPLETED ·Phase: PHASE2

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

NCT00113295 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

NCT00612859 ·Status: COMPLETED ·Phase: PHASE2

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

NCT04524975 ·Status: COMPLETED ·Phase: PHASE2